VEON Subsidiary Kyivstar Acquires Tabletki.ua for $160M, Expanding Digital Healthcare in Ukraine
Summary
VEON's subsidiary Kyivstar acquired Tabletki.ua for $160 million, significantly expanding its digital healthcare services and reinforcing its strategic investment in Ukraine.
Key Events
-
Strategic Acquisition Completed
VEON's subsidiary, Kyivstar Group Ltd., acquired 100% of Tabletki.ua for USD 160 million, payable in Ukrainian hryvna.
-
Expansion of Digital Healthcare Ecosystem
The acquisition strengthens Kyivstar's growing healthcare ecosystem, complementing its earlier acquisition of the digital healthcare platform Helsi in 2022.
-
Leading Digital Pharmacy Platform
Tabletki.ua is a widely used digital platform in Ukraine for finding, comparing, and reserving medicines, facilitating an average of 14 million reservations per month in 2025.
-
Financial Metrics of Acquired Entity
Tabletki.ua generated LTM EBITDA of USD 24 million and LTM net profit of USD 20 million as of September 30, 2025, with the acquisition price corresponding to an 8.0x LTM earnings ratio.
Analysis
VEON's subsidiary, Kyivstar, has completed a significant acquisition of Tabletki.ua for $160 million, a move that substantially expands its digital healthcare ecosystem in Ukraine. This acquisition, representing over 4% of VEON's market capitalization, is a strategic step to integrate a leading digital pharmacy platform with Kyivstar's existing healthcare services, such as Helsi. The deal highlights VEON's commitment to investing in Ukraine's digital infrastructure and services, potentially driving growth in a key market.
At the time of this filing, VEON was trading at $54.09 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $34.55 to $64.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.